13013-15-5

Upstream product

• 41821-45-8 4-(2-chloro-propyl)-morpholine 
• 60678-46-8 N-(2,2-diphenylacetyl)pyrrolidine 
• 123-75-1 pyrrolidine 

Relevant academic research and scientific papers

Combination of selected opioids with muscarine antagonists for treating urinary incontinence

Active compound combinations of compounds of group A, particularly opioids, and compounds of group B, particularly anti-muscarine agents and other substances suitable for treatment of an increased urge to urinate or urinary incontinence. Related pharmaceutical formulations and methods of treatment of an increased urge to urinate or urinary incontinence are also provided.